An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...
CAMBRIDGE, England, September 23, 2025--(BUSINESS WIRE)--Healx, the AI-powered biotech company pioneering the next generation of drug discovery for rare diseases, today announced it has entered into a ...
A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...
Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found. Daily aspirin reduced by 55% the risk of cancer recurrence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback